Free Trial
NASDAQ:BMGL

Basel Medical Group (BMGL) Stock Price, News & Analysis

Basel Medical Group logo
$2.43 -0.24 (-8.99%)
As of 06/20/2025 04:00 PM Eastern

About Basel Medical Group Stock (NASDAQ:BMGL)

Key Stats

Today's Range
$2.35
$2.70
50-Day Range
$1.02
$5.09
52-Week Range
$0.91
$9.40
Volume
371,173 shs
Average Volume
14.63 million shs
Market Capitalization
$44.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Receive BMGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Basel Medical Group and its competitors with MarketBeat's FREE daily newsletter.

BMGL Stock News Headlines

Basel Medical Group Ltd
Wall Street Zen Downgrades Basel Medical Group (NASDAQ:BMGL) to Sell
Recession Fears Mounting? 2 AI Stocks to Watch Now
2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines. But even in uncertain times, innovation doesn’t slow down. In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles. Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar.
Basel Medical Group Ltd.
BMGL Basel Medical Group Ltd
Basel Medical Group Ltd (BMGL)
See More Headlines

BMGL Stock Analysis - Frequently Asked Questions

Basel Medical Group's stock was trading at $4.50 at the beginning of 2025. Since then, BMGL stock has decreased by 46.0% and is now trading at $2.43.
View the best growth stocks for 2025 here
.

Basel Medical Group (BMGL) raised $9 million in an initial public offering (IPO) on Tuesday, February 25th 2025. The company issued 2,205,000 shares at a price of $4.00 per share.

Basel Medical Group's lock-up period expires on Monday, August 25th. Basel Medical Group had issued 2,205,000 shares in its public offering on February 25th. The total size of the offering was $8,820,000 based on an initial share price of $4.00. After the end of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Shares of BMGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BMGL
Web
N/A
Fax
N/A
Employees
36
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$44.83 million
Optionable
N/A
Beta
N/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:BMGL) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners